1
CJC-1295
Evidence Level: preclinical
muscle-growth, fat-loss
Read more →
Best Compounds for Muscle Growth
Photo by Leon Martinez / Pexels
Most people assume growth hormone directly builds muscle. Here's the plot twist: it doesn't. GH triggers your liver to produce IGF-1, which then acts on muscle tissue itself. Understanding this GH-IGF-1 relay system is the key to why CJC-1295 and Ipamorelin appear together in muscle research conversations.
How the GH-IGF-1 Axis Drives Muscle Protein Synthesis
Growth hormone doesn't build muscle directly. It signals the liver to produce IGF-1, which then acts on muscle tissue. Research suggests this GH-IGF-1 axis is a primary driver of protein synthesis and satellite cell activation [PMID: 16352683].
Satellite cells are the repair and growth units of muscle fiber. IGF-1 signals them to proliferate after mechanical stress — which is why the GH axis matters specifically in training contexts.
What CJC-1295 Research Shows for Muscle
CJC-1295's defining feature is its extended half-life via DAC modification: 6–8 days rather than the 30-minute half-life of native GHRH. This creates sustained GH elevation rather than the pulsatile pattern seen naturally [PMID: 16352683].
Animal studies indicate increased lean body mass with chronic GH elevation. In healthy humans, whether this translates to meaningful muscle gains at research dosages remains unclear from published literature.
What Ipamorelin Research Shows for Muscle
Ipamorelin produces selective GH release — stimulating the pituitary without substantially raising cortisol or ACTH levels. This selectivity matters because cortisol is catabolic and would partially offset any anabolic benefit [PMID: 16352683].
The 2-hour half-life creates a more physiologic pulsatile GH pattern compared to CJC-1295. Researchers often combine both compounds to achieve simultaneous pulsatile and basal GH elevation.
What the Evidence Gap Means
The anabolic mechanism is well-documented in animal models and clinical GH-deficient populations. But healthy-subject muscle-building data at typical research dosages is largely absent from the literature.
GH secretagogues are not anabolic steroids. The magnitude of effect in healthy adults with normal GH levels is unknown and probably modest compared to exogenous GH.
Quick Comparison
| Compound | Tier | Evidence for This Use Case | Mechanisms of Action | Half-Life | Admin Routes |
|---|---|---|---|---|---|
| 1 CJC-1295 | Tier 1 | preclinical | GHRH receptor agonism → pulsatile GH secretion, Drug Affinity Complex (DAC) binding extends half-life | 6–8 days (with DAC modification); 30 minutes (without DAC) | subcutaneous, intramuscular |
| Tier 1 | preclinical | Selective GH release via ghrelin receptor (GHSR-1a) agonism, Minimal effect on cortisol and prolactin (selectivity advantage) | approximately 2 hours | subcutaneous, intramuscular |
Researched Compounds
Evidence Level: preclinical
muscle-growth, fat-loss
Read more →Where to Source
Where to sourceResearch use only
Limitless Life Nootropics — CJC-1295
Use coupon
at checkoutCompound15Affiliate link — we may earn a commission at no extra cost to you. Research compounds are for laboratory use only.
Where to sourceResearch use only
Limitless Life Nootropics — Ipamorelin
Use coupon
at checkoutCompound15Affiliate link — we may earn a commission at no extra cost to you. Research compounds are for laboratory use only.
Frequently Asked Questions
-
Growth hormone itself doesn't directly stimulate muscle contraction or protein synthesis. Instead, GH signals the liver to produce IGF-1, which then acts on muscle tissue to promote protein synthesis and amino acid uptake. Think of GH as the messenger telling your liver to manufacture IGF-1, and IGF-1 as the actual builder. This two-step cascade is what researchers measure in muscle growth studies.
-
CJC-1295 works via the GHRH receptor (a long-acting signal with a 6–8 day half-life), while Ipamorelin works via the ghrelin receptor (producing acute pulses with a 2-hour half-life). CJC-1295 creates sustained GH elevation; Ipamorelin creates pulsatile GH release. Additionally, Ipamorelin stimulates GH with minimal cortisol elevation, whereas many other GH secretagogues raise both GH and cortisol together.
-
They activate different receptor pathways that both lead to GH release. By combining them, researchers theoretically achieve more complete GH pulsatile secretion across two complementary signaling mechanisms. Animal data suggests a synergistic effect, but human studies comparing the combination to either compound alone are limited.
-
The evidence is preclinical. Animal models and cell culture studies show that GH and IGF-1 influence muscle protein synthesis reliably. However, human body composition studies — measuring actual muscle gain in real people — are sparse. These compounds remain research-only in most jurisdictions, and claims about lean mass gains should be interpreted carefully.
-
Cortisol is catabolic — it breaks down muscle protein and opposes the anabolic signaling from IGF-1. If a GH secretagogue also raises cortisol substantially, the net effect on muscle protein balance becomes less favorable. This is why Ipamorelin's selectivity (raising GH without raising cortisol) is theoretically advantageous for muscle anabolism compared to non-selective GH secretagogues.